OptimizeRx to Present at William Blair & Company's 40th Annual Growth Stock Conference, June 9-11, 2020
29 Mai 2020 - 2:31PM
OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital
health solutions for life science companies, payers and providers,
has been invited to present in William Blair & Company’s 40th
Annual Growth Stock Conference being held June 9-11, 2020.
OptimizeRx CEO William Febbo is scheduled to present on June 10,
2020, at 9:20 a.m. Central time, as well as participate in virtual
one-on-one meetings on the same day and June 11.
He will discuss a number of topics, including how OptimizeRx’s
record Q1 results demonstrated an acceleration in platform adoption
and the further transformation of the company’s revenue model into
SaaS-based enterprise-level deployments. He will also discuss how
COVID-19 has made OptimizeRx’s nationwide digital connectivity at
the point-of-care even more relevant to its customer base, which
now includes the world’s top 20 pharmaceutical companies.
The live presentation will be available at
investors.optimizerx.com/events-and-presentations.
The event is for institutional clients of William Blair and is
by invitation only. To schedule a one-on-one meeting with
OptimizeRx, please contact your William Blair institutional sales
representative. For further assistance or any questions about
OptimizeRx, contact Ron Both of CMA at (949) 432-7557 or submit
your inquiry here.
About William BlairWilliam Blair is a premier
global boutique with expertise in investment banking, investment
management, and private wealth management. The company provides
advisory services, strategies, and solutions to meet its clients’
evolving needs. As an independent and employee-owned firm, together
with its strategic partners, William Blair operates in more than 20
offices worldwide. For more information, visit
www.williamblair.com.
About OptimizeRx®OptimizeRx
Corporation (NASDAQ: OPRX) is a digital health company that
facilitates communication at point-of-care among all stakeholders
in healthcare. Primarily focused on life science and payer clients,
its suite of digital and mobile SaaS-based solutions enables
affordability, patient adherence and care management. OptimizeRx’s
network reaches more than 60% of U.S. ambulatory providers,
delivering therapeutic support on specialty medications and patient
financial assistance directly within a provider’s workflow through
leading electronic health platforms. OptimizeRx’s fully integrated
platform supports the real-time exchange of information, improving
provider knowledge and patient engagement, and ultimately leading
to healthier outcomes.
For more information, go to OptimizeRx.com, and follow the
company on Twitter and LinkedIn.
Important Cautions Regarding Forward Looking
StatementsThis press release contains forward-looking
statements within the definition of Section 27A of the Securities
Act of 1933, as amended, and such as in section 21E of the
Securities Act of 1934, as amended. These forward-looking
statements should not be used to make an investment decision. The
words 'estimate,' 'possible' and 'seeking' and similar expressions
identify forward-looking statements, which speak only as to the
date the statement was made. The company undertakes no obligation
to publicly update or revise any forward-looking statements,
whether because of new information, future events, or otherwise.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted, or quantified.
Future events and actual results could differ materially from those
set forth in, contemplated by, or underlying the forward-looking
statements. The risks and uncertainties to which forward-looking
statements are subject include, but are not limited to, the effect
of government regulation, competition, and other material
risks.
OptimizeRx Contact Doug Baker, CFOTel (248)
651-6568 x807 dbaker@optimizerx.com
Media Relations Contact Maira Alejandra, Media
Relations ManagerTel (754) 245-7070 malejandra@optimizerx.com
Investor Relations Contact Ron Both or Grant
StudeCMA Investor RelationsTel (949) 432-7557 oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024